Mol Genet Metab Rep
An open-label uncontrolled trial including 27 patients with T2D and NAFLD treated with liraglutide 0.9 mg/day for 24 weeks showed a trend toward increases in liver-to-spleen attenuation ratio assessed by CT scan and, more importantly, a significant improvement in histological inflammatory scores in 10 subjects undergoing liver biopsies after a prolonged treatment of 96 weeks (64)
Zinman B, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, et al
Rebuilding bulk and texture is often the most complex challenge, particularly in applications like dairy, frozen desserts, and baked goods where sugar significantly contributes to structure and stability, Diedrich underscores
Aging & Mental Health 28(12):1767-1776
b) Alkem & Biocon:Strong contenders in the Indian market